RxDoctor Payments Data

Judy Carrico

Nurse Practitioner · Owensboro, KYNPI 1649251349

Payments from drug & device makers

$2,612in general payments, 2019–2025

Across 158 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$378
  • Novo Nordisk$325
  • Lilly USA, LLC$310
  • Amgen$223
  • AstraZeneca$209
  • Novartis$81
  • plus $1K from 32 others

What the payments were for

  • Food & beverage$2,612100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,612 in reported general payments places this provider in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$87,680
Medicare patients
227
Services billed
1,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide102$114,942
MounjaroTirzepatide63$73,921
FarxigaDapagliflozin Propanediol46$45,435
TrulicityDulaglutide37$41,251
EliquisApixaban45$40,730
JanuviaSitagliptin Phosphate39$35,758
Repatha SureclickEvolocumab29$29,475
JardianceEmpagliflozin21$29,417
ProliaDenosumab13$22,869
Tresiba Flextouch U-200Insulin Degludec19$22,322
MyrbetriqMirabegron22$15,585
JanumetSitagliptin Phos/Metformin Hcl12$15,572
RybelsusSemaglutide14$13,151
GemtesaVibegron18$11,128
NovologInsulin Aspart17$8,671

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$325$136,764133 claims
Lilly USA, LLCMounjaro, Trulicity$310$115,172100 claims
AstraZenecaFarxiga$209$45,43546 claims
PfizerEliquis$54$40,73045 claims
Boehringer IngelheimJardiance$67$29,41721 claims
AmgenProlia$223$22,86913 claims
Astellas Pharma US IncMyrbetriq$35$15,58522 claims
Sumitomo Pharma America, Inc.Gemtesa$38$11,12818 claims
AbbVieSynthroid$378$4,99793 claims
Sanofi-aventis U.S. LLCLantus$15$2,62619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Owensboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →